Javascript er ikke aktivert i din nettleser. Dette er nødvendig for å bruke Oncolex. Kontakt din systemadministrator for å aktivere JavaScript.

Prognosis of colon and rectum cancer

The prognosis depends on whether the colon and rectum cancer is localized, regional, or metastatic at the time of diagnosis. 39.2% are diagnosed at the local stage and the 5-year survival for localized colon and rectum cancer is 89.9%. The overall 5-year survival rate for colon and rectum cancer patients during the period 2007-2013 was 64.9%.

Colon and rectum cancer is the second leading cause of cancer death in the United States. The number of  deaths is highest among people aged 75-84. Death rates have been falling on average 2.7% each year over 2004-2013.

In 2014, there were an estimated 1,317,247 people living with colon and rectum cancer in the United States and in 2017 there are an estimated 50,260 people will die of this disease. (18)




Oslo University Hospital shall not be liable for any loss whether direct, indirect, incidental or consequential, arising out of access to, use of, or reliance upon any of the content on this website. Oslo University Hospital© 2018